You’re innovating. Regulatory shouldn’t slow you down.
For medtech and digital health startups that need to make fast decisions without getting stuck in regulatory uncertainty.
Inside many startups, product development moves fast while regulatory clarity lags behind. Key decisions are made with incomplete information, and answers often come only after time and budget have already been spent.
The result is rework, delays, and a longer path to getting your technology into the hands of patients.
Sounds familiar?
Speed mismatch
Your products move fast. Your regulatory process does not.
Shifting assumptions
Early product decisions rely on assumptions that change after deeper regulatory review.
Costly fallback
External consultants are expensive and rarely available when timelines tighten.
Unpredictable outcome
Slow decisions, late surprises, and senior experts stuck in PDFs instead of moving products and trials forward.
Guideways gives you early, structured insight into classification, pathways, requirements, and compliance expectations. Your team stays in control of decisions, but no longer has to rely on fragmented input or delayed feedback.
AI agents built for startup teams navigating regulatory approval
Guideways acts as your regulatory guide from the moment you define your product. It focuses on the stages where startups face the most uncertainty: early planning, internal alignment, and preparing for what comes next.
FDA Sherpa
Understand your path early
Turn a device description into clear classification options and likely regulatory pathways, identify relevant predicates along with key regulations and guidances, and use this insight to plan clinical and development strategy based on evidence rather than guesswork.
FDA Reviewer
Find gaps before regulators do
Map documents against identified requirements, flag missing sections, inconsistencies, and weak support, and get a structured submission readiness view with clear, prioritized actions.
FDA Researcher
Stronger answers, fewer document deep-dives
Regulatory research tuned to medtech questions, delivering results pulled from regulations, guidances, standards, and approvals, with structured answers and linked references you can use directly in memos, risk assessments, and justifications.
Guideways supports the points where regulatory work slows teams down
Intake and early discussion for new devices
Internal pre-submission reviews and sign-off
Cross-functional meetings around regulatory strategy
Ongoing questions from R&D and clinical teams
Outputs can be exported and attached to the systems you already use. RA/QA stays in charge of interpretation and decisions. Guideways makes the underlying analysis more consistent, traceable, and easier to explain.
“Guideways made it easy and accessible for us to quickly assess where we stand and how to proceed.”
What does this unlock for your team?
Move from idea to a clear regulatory direction earlier, avoid costly pivots later in development, and make better use of limited time and resources. You gain clearer documentation to support investor conversations and future submissions, while reducing reliance on external consultants for repetitive work. If this sounds familiar, we can walk through your product in a live demo.
We can show the full workflow on one of your devices in a live demo.
Join the Guideways Explorer Community
Guideways has been shaped alongside an early group of founders and regulatory teams facing the same challenges, and this launch reflects their input.
Join the Guideways Explorer Community to get early access to new features, contribute to product development, and learn from how other teams approach regulatory decisions.